US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist

16.230
+0.400+2.53%

Close Sep 27 16:00 ET

16.240
+0.010+0.06%

Post 18:41 ET

1.46BMarket Cap-6194P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Total revenue

32.73%2.28M

-83.76%1.4M

-86.28%14.09M

1.72M

8.63M

102.69M

Operating revenue

32.73%2.28M

-83.76%1.4M

-86.28%14.09M

--1.72M

--8.63M

--102.69M

--0

Cost of revenue

Gross profit

Operating expense

31.83%53.68M

18.48%55.99M

87.77%189.2M

40.72M

47.26M

190.78%100.76M

433.78%34.65M

6.49M

Selling and administrative expenses

139.97%15.3M

98.33%13.56M

112.42%29.77M

--6.38M

--6.84M

146.87%14.02M

274.65%5.68M

--1.52M

-Selling and marketing expense

650.96%3.52M

559.39%4.08M

137.33%4.06M

--469K

--618K

74.92%1.71M

7,121.27%977K

--13.53K

-General and administrative expense

99.39%11.78M

52.52%9.49M

108.96%25.72M

--5.91M

--6.22M

161.83%12.31M

212.96%4.7M

--1.5M

Research and development costs

11.76%38.38M

4.97%42.43M

83.79%159.42M

--34.34M

--40.42M

199.39%86.74M

482.37%28.97M

--4.98M

Depreciation amortization depletion

----

--1.23K

-Depreciation and amortization

----

--1.23K

Operating profit

-31.79%-51.4M

-41.32%-54.59M

-9,149.35%-175.11M

-39M

-38.63M

105.58%1.94M

-433.78%-34.65M

-6.49M

Net non-operating interest income expense

226.81%3.69M

876.60%2.19M

159.20%3.42M

1.13M

-282K

-684.12%-5.78M

-21.05%-737K

-608.83K

Non-operating interest income

5.57%4.87M

226.94%3.08M

--11.28M

--4.61M

--943K

--0

Non-operating interest expense

----

--0

----

-30.17%287K

-2.86%411K

--423.1K

Total other finance cost

-66.21%1.18M

-27.10%893K

43.15%7.86M

--3.48M

--1.23M

1,584.66%5.49M

75.53%326K

--185.72K

Other net income (expense)

2,161.14%8.7M

-1,231.02%-41.37M

72.19%-5.23M

-422K

-3.11M

-193.73%-18.79M

-21,770.90%-6.4M

29.52K

Gain on sale of security

2,161.14%8.7M

-1,231.02%-41.37M

51.56%-5.23M

---422K

---3.11M

-732.36%-10.79M

5,679.36%1.71M

--29.52K

Special income (charges)

----

--0

----

--0

---883K

--0

-Less：Restructuring and merger&acquisition

----

--0

-Less:Other special charges

----

--883K

----

Other non- operating income (expenses)

----

-10.83%-8M

---7.22M

----

Income before tax

-1.87%-39.01M

-123.16%-93.77M

-681.61%-176.91M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

-7.07M

Income tax

27K

Net income

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

-7.07M

Net income continuous Operations

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

---38.29M

---42.02M

45.83%-22.63M

-490.94%-41.79M

---7.07M

Minority interest income

Net income attributable to the parent company

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

-7.07M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

-7.07M

Basic earnings per share

12.77%-0.41

-107.84%-1.06

-80.67%-2.15

-0.47

-0.51

-132.27%-1.19

-490.94%-0.5123

-0.0867

Diluted earnings per share

12.77%-0.41

-107.84%-1.06

-80.67%-2.15

-0.47

-0.51

-132.27%-1.19

-490.94%-0.5123

-0.0867

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Total revenue	32.73%2.28M	-83.76%1.4M	-86.28%14.09M	1.72M	8.63M	102.69M	0	0
Operating revenue	32.73%2.28M	-83.76%1.4M	-86.28%14.09M	--1.72M	--8.63M	--102.69M	--0	--0
Cost of revenue
Gross profit
Operating expense	31.83%53.68M	18.48%55.99M	87.77%189.2M	40.72M	47.26M	190.78%100.76M	433.78%34.65M	6.49M
Selling and administrative expenses	139.97%15.3M	98.33%13.56M	112.42%29.77M	--6.38M	--6.84M	146.87%14.02M	274.65%5.68M	--1.52M
-Selling and marketing expense	650.96%3.52M	559.39%4.08M	137.33%4.06M	--469K	--618K	74.92%1.71M	7,121.27%977K	--13.53K
-General and administrative expense	99.39%11.78M	52.52%9.49M	108.96%25.72M	--5.91M	--6.22M	161.83%12.31M	212.96%4.7M	--1.5M
Research and development costs	11.76%38.38M	4.97%42.43M	83.79%159.42M	--34.34M	--40.42M	199.39%86.74M	482.37%28.97M	--4.98M
Depreciation amortization depletion	----	----	----	----	----	----	----	--1.23K
-Depreciation and amortization	----	----	----	----	----	----	----	--1.23K
Operating profit	-31.79%-51.4M	-41.32%-54.59M	-9,149.35%-175.11M	-39M	-38.63M	105.58%1.94M	-433.78%-34.65M	-6.49M
Net non-operating interest income expense	226.81%3.69M	876.60%2.19M	159.20%3.42M	1.13M	-282K	-684.12%-5.78M	-21.05%-737K	-608.83K
Non-operating interest income	5.57%4.87M	226.94%3.08M	--11.28M	--4.61M	--943K	--0	--0	--0
Non-operating interest expense	----	----	--0	----	----	-30.17%287K	-2.86%411K	--423.1K
Total other finance cost	-66.21%1.18M	-27.10%893K	43.15%7.86M	--3.48M	--1.23M	1,584.66%5.49M	75.53%326K	--185.72K
Other net income (expense)	2,161.14%8.7M	-1,231.02%-41.37M	72.19%-5.23M	-422K	-3.11M	-193.73%-18.79M	-21,770.90%-6.4M	29.52K
Gain on sale of security	2,161.14%8.7M	-1,231.02%-41.37M	51.56%-5.23M	---422K	---3.11M	-732.36%-10.79M	5,679.36%1.71M	--29.52K
Special income (charges)	----	----	--0	----	----	--0	---883K	--0
-Less：Restructuring and merger&acquisition	----	----	----	----	----	----	----	--0
-Less:Other special charges	----	----	----	----	----	----	--883K	----
Other non- operating income (expenses)	----	----	----	----	----	-10.83%-8M	---7.22M	----
Income before tax	-1.87%-39.01M	-123.16%-93.77M	-681.61%-176.91M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M	-7.07M
Income tax	0	0	27K	0	0	0	0	0
Net income	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M	-7.07M
Net income continuous Operations	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	---38.29M	---42.02M	45.83%-22.63M	-490.94%-41.79M	---7.07M
Minority interest income
Net income attributable to the parent company	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M	-7.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M	-7.07M
Basic earnings per share	12.77%-0.41	-107.84%-1.06	-80.67%-2.15	-0.47	-0.51	-132.27%-1.19	-490.94%-0.5123	-0.0867
Diluted earnings per share	12.77%-0.41	-107.84%-1.06	-80.67%-2.15	-0.47	-0.51	-132.27%-1.19	-490.94%-0.5123	-0.0867
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data